Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects.

Valle A, Catalán V, Rodríguez A, Rotellar F, Valentí V, Silva C, Salvador J, Frühbeck G, Gómez-Ambrosi J, Roca P, Oliver J.

Liver Int. 2012 Jul;32(6):951-61. doi: 10.1111/j.1478-3231.2012.02765.x. Epub 2012 Feb 19.

PMID:
22340678
2.

Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.

Calvo N, Beltrán-Debón R, Rodríguez-Gallego E, Hernández-Aguilera A, Guirro M, Mariné-Casadó R, Millá L, Alegret JM, Sabench F, del Castillo D, Vinaixa M, Rodríguez MÀ, Correig X, García-Álvarez R, Menendez JA, Camps J, Joven J.

World J Gastroenterol. 2015 Jun 28;21(24):7529-44. doi: 10.3748/wjg.v21.i24.7529.

3.

Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease.

Ma H, Gomez V, Lu L, Yang X, Wu X, Xiao SY.

J Gastroenterol Hepatol. 2009 Feb;24(2):233-7. doi: 10.1111/j.1440-1746.2008.05548.x. Epub 2008 Aug 17.

PMID:
18713296
4.

Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.

Walle P, Takkunen M, Männistö V, Vaittinen M, Lankinen M, Kärjä V, Käkelä P, Ågren J, Tiainen M, Schwab U, Kuusisto J, Laakso M, Pihlajamäki J.

Metabolism. 2016 May;65(5):655-66. doi: 10.1016/j.metabol.2016.01.011. Epub 2016 Jan 23.

PMID:
27085774
5.

Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.

Praveenraj P, Gomes RM, Kumar S, Karthikeyan P, Shankar A, Parthasarathi R, Senthilnathan P, Rajapandian S, Palanivelu C.

Obes Surg. 2015 Nov;25(11):2078-87. doi: 10.1007/s11695-015-1655-1.

PMID:
25835982
6.

Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans.

Männistö VT, Simonen M, Hyysalo J, Soininen P, Kangas AJ, Kaminska D, Matte AK, Venesmaa S, Käkelä P, Kärjä V, Arola J, Gylling H, Cederberg H, Kuusisto J, Laakso M, Yki-Järvinen H, Ala-Korpela M, Pihlajamäki J.

Liver Int. 2015 Jul;35(7):1853-61. doi: 10.1111/liv.12769. Epub 2015 Jan 20.

PMID:
25533197
7.

Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease.

Auguet T, Terra X, Quintero Y, Martínez S, Manresa N, Porras JA, Aguilar C, Orellana-Gavaldà JM, Hernández M, Sabench F, Lucas A, Pellitero S, Del Castillo D, Richart C.

Exp Clin Endocrinol Diabetes. 2013 Feb;121(2):119-24. doi: 10.1055/s-0032-1331696. Epub 2013 Feb 20.

PMID:
23426707
8.

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

Weiner RA.

Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7.

PMID:
20460923
9.

Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes.

Narasimhan S, Gokulakrishnan K, Sampathkumar R, Farooq S, Ravikumar R, Mohan V, Balasubramanyam M.

Clin Biochem. 2010 Jul;43(10-11):815-21. doi: 10.1016/j.clinbiochem.2010.04.003. Epub 2010 Apr 14.

PMID:
20398645
10.

Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Ulukaya E, Yilmaz Y, Moshkovskii S, Karpova M, Pyatnitskiy M, Atug O, Dolar E.

Scand J Gastroenterol. 2009;44(12):1471-6. doi: 10.3109/00365520903353379.

PMID:
19883279
11.

Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.

Colicchio P, Tarantino G, del Genio F, Sorrentino P, Saldalamacchia G, Finelli C, Conca P, Contaldo F, Pasanisi F.

Ann Nutr Metab. 2005 Sep-Oct;49(5):289-95. Epub 2005 Aug 2.

PMID:
16088092
12.

Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.

Koliaki C, Roden M.

Mol Cell Endocrinol. 2013 Oct 15;379(1-2):35-42. doi: 10.1016/j.mce.2013.06.002. Epub 2013 Jun 12. Review.

PMID:
23770462
13.

Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury.

Serviddio G, Bellanti F, Tamborra R, Rollo T, Capitanio N, Romano AD, Sastre J, Vendemiale G, Altomare E.

Gut. 2008 Jul;57(7):957-65. doi: 10.1136/gut.2007.147496. Epub 2008 Feb 28.

PMID:
18308829
14.

Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.

Rametta R, Mozzi E, Dongiovanni P, Motta BM, Milano M, Roviaro G, Fargion S, Valenti L.

Int J Obes (Lond). 2013 Jul;37(7):986-92. doi: 10.1038/ijo.2012.181. Epub 2012 Nov 13.

PMID:
23147115
15.

Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.

Aron-Wisnewsky J, Minville C, Tordjman J, Lévy P, Bouillot JL, Basdevant A, Bedossa P, Clément K, Pépin JL.

J Hepatol. 2012 Jan;56(1):225-33. doi: 10.1016/j.jhep.2011.04.022. Epub 2011 May 19.

PMID:
21703181
16.

Irisin in patients with nonalcoholic fatty liver disease.

Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS.

Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18.

PMID:
24140091
17.

Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease.

Charlton M, Viker K, Krishnan A, Sanderson S, Veldt B, Kaalsbeek AJ, Kendrick M, Thompson G, Que F, Swain J, Sarr M.

Hepatology. 2009 Apr;49(4):1375-84. doi: 10.1002/hep.22927.

18.

SFRP5 hepatic expression is associated with non-alcoholic liver disease in morbidly obese women.

Gutiérrez-Vidal R, Vega-Badillo J, Reyes-Fermín LM, Hernández-Pérez HA, Sánchez-Muñoz F, López-Álvarez GS, Larrieta-Carrasco E, Fernández-Silva I, Méndez-Sánchez N, Tovar AR, Villamil-Ramírez H, Mejía-Domínguez AM, Villarreal-Molina T, Hernández-Pando R, Campos-Pérez F, Aguilar-Salinas CA, Canizales-Quinteros S.

Ann Hepatol. 2015 Sep-Oct;14(5):666-74.

19.

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.

Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.

Obes Surg. 2005 Mar;15(3):310-5.

PMID:
15826462
20.

Supplemental Content

Support Center